Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q2 2021 · 10-Q
Revenue$15.14M$15.14M−4.8% vs Q2 2020 Net Income-$8.40M-$8.40MN/M vs Q2 2020 EPS Diluted-$0.99-$0.99N/M vs Q2 2020 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,938,000N/M Margins · derivedGross margin-1.7%−7.3 pt vs Q2 2020
Operating margin-51.7%−16.4 pt vs Q2 2020
Net margin-55.5%−12.1 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end